These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1158 related articles for article (PubMed ID: 31477562)

  • 1. Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment.
    Nagpal R; Neth BJ; Wang S; Craft S; Yadav H
    EBioMedicine; 2019 Sep; 47():529-542. PubMed ID: 31477562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut mycobiome and its interaction with diet, gut bacteria and alzheimer's disease markers in subjects with mild cognitive impairment: A pilot study.
    Nagpal R; Neth BJ; Wang S; Mishra SP; Craft S; Yadav H
    EBioMedicine; 2020 Sep; 59():102950. PubMed ID: 32861197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified ketogenic diet is associated with improved cerebrospinal fluid biomarker profile, cerebral perfusion, and cerebral ketone body uptake in older adults at risk for Alzheimer's disease: a pilot study.
    Neth BJ; Mintz A; Whitlow C; Jung Y; Solingapuram Sai K; Register TC; Kellar D; Lockhart SN; Hoscheidt S; Maldjian J; Heslegrave AJ; Blennow K; Cunnane SC; Castellano CA; Zetterberg H; Craft S
    Neurobiol Aging; 2020 Feb; 86():54-63. PubMed ID: 31757576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a ketogenic and low-fat diet on the human metabolome, microbiome, and foodome in adults at risk for Alzheimer's disease.
    Dilmore AH; Martino C; Neth BJ; West KA; Zemlin J; Rahman G; Panitchpakdi M; Meehan MJ; Weldon KC; Blach C; Schimmel L; Kaddurah-Daouk R; Dorrestein PC; Knight R; Craft S;
    Alzheimers Dement; 2023 Nov; 19(11):4805-4816. PubMed ID: 37017243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum and CSF metabolomics analysis shows Mediterranean Ketogenic Diet mitigates risk factors of Alzheimer's disease.
    Schweickart A; Batra R; Neth BJ; Martino C; Shenhav L; Zhang AR; Shi P; Karu N; Huynh K; Meikle PJ; Schimmel L; Dilmore AH; Blennow K; Zetterberg H; Blach C; Dorrestein PC; Knight R; ; Craft S; Kaddurah-Daouk R; Krumsiek J
    NPJ Metab Health Dis; 2024; 2(1):15. PubMed ID: 38962750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Modified Mediterranean Ketogenic Diet mitigates modifiable risk factors of Alzheimer's Disease: a serum and CSF-based metabolic analysis.
    Schweickart A; Batra R; Neth BJ; Martino C; Shenhav L; Zhang AR; Shi P; Karu N; Huynh K; Meikle PJ; Schimmel L; Dilmore AH; Blennow K; Zetterberg H; Blach C; Dorrestein PC; Knight R; ; Craft S; Kaddurah-Daouk R; Krumsiek J
    medRxiv; 2023 Nov; ():. PubMed ID: 38076824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered Gut Microbial Metabolites in Amnestic Mild Cognitive Impairment and Alzheimer's Disease: Signals in Host-Microbe Interplay.
    Wu L; Han Y; Zheng Z; Peng G; Liu P; Yue S; Zhu S; Chen J; Lv H; Shao L; Sheng Y; Wang Y; Li L; Li L; Wang B
    Nutrients; 2021 Jan; 13(1):. PubMed ID: 33466861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketogenic diet rescues cognition in ApoE4+ patient with mild Alzheimer's disease: A case study.
    Morrill SJ; Gibas KJ
    Diabetes Metab Syndr; 2019; 13(2):1187-1191. PubMed ID: 31336463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered microbiomes distinguish Alzheimer's disease from amnestic mild cognitive impairment and health in a Chinese cohort.
    Liu P; Wu L; Peng G; Han Y; Tang R; Ge J; Zhang L; Jia L; Yue S; Zhou K; Li L; Luo B; Wang B
    Brain Behav Immun; 2019 Aug; 80():633-643. PubMed ID: 31063846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota.
    Li B; He Y; Ma J; Huang P; Du J; Cao L; Wang Y; Xiao Q; Tang H; Chen S
    Alzheimers Dement; 2019 Oct; 15(10):1357-1366. PubMed ID: 31434623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of Gut Microbiota Through Dietary Intervention in Neuroinflammation and Alzheimer's and Parkinson's Diseases.
    Ayten Ş; Bilici S
    Curr Nutr Rep; 2024 Jun; 13(2):82-96. PubMed ID: 38652236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Free water in gray matter linked to gut microbiota changes with decreased butyrate producers in Alzheimer's disease and mild cognitive impairment.
    Yamashiro K; Takabayashi K; Kamagata K; Nishimoto Y; Togashi Y; Yamauchi Y; Ogaki K; Li Y; Hatano T; Motoi Y; Suzuki M; Miyakawa K; Ishikawa D; Aoki S; Urabe T; Hattori N
    Neurobiol Dis; 2024 Apr; 193():106464. PubMed ID: 38452948
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Tran TTT; Corsini S; Kellingray L; Hegarty C; Le Gall G; Narbad A; Müller M; Tejera N; O'Toole PW; Minihane AM; Vauzour D
    FASEB J; 2019 Jul; 33(7):8221-8231. PubMed ID: 30958695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A modified Mediterranean-style diet enhances brain function via specific gut-microbiome-brain mechanisms.
    Park G; Kadyan S; Hochuli N; Pollak J; Wang B; Salazar G; Chakrabarty P; Efron P; Sheffler J; Nagpal R
    Gut Microbes; 2024; 16(1):2323752. PubMed ID: 38444392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-An emerging role for gut microbiome.
    MahmoudianDehkordi S; Arnold M; Nho K; Ahmad S; Jia W; Xie G; Louie G; Kueider-Paisley A; Moseley MA; Thompson JW; St John Williams L; Tenenbaum JD; Blach C; Baillie R; Han X; Bhattacharyya S; Toledo JB; Schafferer S; Klein S; Koal T; Risacher SL; Kling MA; Motsinger-Reif A; Rotroff DM; Jack J; Hankemeier T; Bennett DA; De Jager PL; Trojanowski JQ; Shaw LM; Weiner MW; Doraiswamy PM; van Duijn CM; Saykin AJ; Kastenmüller G; Kaddurah-Daouk R;
    Alzheimers Dement; 2019 Jan; 15(1):76-92. PubMed ID: 30337151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ketogenic diet mitigates opioid-induced hyperalgesia by restoring short-chain fatty acids-producing bacteria in the gut.
    Crawford J; Liu S; Tao R; Kramer P; Bender S; Tao F
    Pain; 2024 Sep; 165(9):e106-e114. PubMed ID: 38452211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Effects of Plant Anthocyanin against Alzheimer's Disease and Modulate Gut Health, Short-Chain Fatty Acids.
    Bayazid AB; Lim BO
    Nutrients; 2024 May; 16(11):. PubMed ID: 38892488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance of the interplay between amyloid and tau for cognitive impairment in early Alzheimer's disease.
    Timmers M; Tesseur I; Bogert J; Zetterberg H; Blennow K; Börjesson-Hanson A; Baquero M; Boada M; Randolph C; Tritsmans L; Van Nueten L; Engelborghs S; Streffer JR
    Neurobiol Aging; 2019 Jul; 79():131-141. PubMed ID: 31055223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary Pattern, Gut Microbiota, and Alzheimer's Disease.
    Zhang M; Zhao D; Zhou G; Li C
    J Agric Food Chem; 2020 Nov; 68(46):12800-12809. PubMed ID: 32090565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the Mediterranean and Ketogenic Diets on Cognitive Status and Decline: A Narrative Review.
    Vinciguerra F; Graziano M; Hagnäs M; Frittitta L; Tumminia A
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32276339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.